News tagged ‘BasicResearch’ clear
- Evidence suggests normal cells in bone marrow reduce cancerous cells' ability to undergo apoptosis.
- A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston
Tags: BasicResearch, Radiation
- An analysis of two dozen clinical studies finds most adults with
poor-risk and intermediate-risk acute myeloid leukemia benefit from
allogeneic stem cell transplants.
Tags: BasicResearch, StemCellTransplant, Leukemia
- A section of the AIDS virus's protein envelope known as the V3 loop and
once considered an improbable target for a vaccine now appears to be one
of the most promising, according to research authored by Dana-Farber's
Ruth Ruprecht, MD, PhD.
Tags: BasicResearch, ImmuneSystem
- Although it sounds like a case of gender confusion on a molecular scale, the male hormone androgen spurs the growth of some breast tumors in women. In a new study, scientists at Dana-Farber Cancer Institute provide the first details of the cancer cell machinery that carries out the hormone’s relentless growth orders.
Tags: BasicResearch, BreastCancer
- Scientists at Dana-Farber Cancer Institute and the University of Colorado Cancer Center report on a gene fusion that spurs the cells to divide rapidly. Treating the cells with a compound that blocks the protein caused the cells to die which may offer a targeted therapy in patients.
Tags: BasicResearch, LungCancer
- Dana-Farber researchers suggest guidelines and provide tools to minimize
inconsistencies in collecting and sharing data on interactions between
- Dana-Farber/Harvard Cancer Center researchers receive six Specialized Program of Research Excellence (SPORE) grants, which support research that moves from the laboratory to the clinic.
Tags: BasicResearch, Grants
- In prostate cancer patients with a certain genetic variant, a high level
of selenium in the blood was associated with a two-fold greater risk of
poorer outcomes than men with the lowest amounts of selenium.
Tags: BasicResearch, ProstateCancer
Showing 11-20 of 110 items